TGFB1 and systemic sclerosis: Additionally, Henderson et al. (2020) performed in vitro studies in dermal fibroblasts derived from SSc patients and stimulated isolated normal healthy dermal fibroblasts (NHDFs) with TGF-β1 to activate fibrotic pathways and measured succinate levels.